Oxford Gene Technology (OGT) provides microarray products and services that enable clinical research and molecular diagnostics in academic, hospital, and government research laboratories all over the world. As one of its key business areas, licensing gives companies access to its intellectual property that covers microarrays, genomics, and electrochemistry. The firm holds more than 20 patent families that cover a range of technologies. OGT's research focuses on developing novel microarray technologies for new applications such as drug discovery and disease diagnosis. The privately owned company was founded in 1995 by Professor Sir Edwin Southern.